Tag: Prescription Drugs
Canakinumab Explored as Therapy for Large-Joint Osteoarthritis
Exploratory analysis reveals total hip/knee replacement rate reduced with canakinumab versus placebo
Cost-Related Rx Nonadherence Highest in Young U.S. Women
One in four women report cost-related nonadherence versus one in seven men
Remdesivir Shortages Plague Some Hospitals, Pharmacists Say
One-third of pharmacists report that they do not have enough remdesivir to treat all eligible patients
Adherence to Prophylaxis for EGFRi-Linked Rash Beneficial
Adherence to prophylaxis protocols tied to drop in interventions, toxicity-linked chemo interruptions
Risk for Heart Failure Increased for Women Taking β-Blockers
Difference of 4.6 percent found between women and men in rate of heart failure at presentation for ACS
Baloxavir Protects Household Contacts From Influenza
Percentage of patients in whom clinical influenza developed significantly lower in baloxavir group
Gilead Presents Additional Data on Efficacy of Remdesivir for COVID-19
Pharma company says there is further evidence remdesivir may reduce deaths, hasten recovery
Nemolizumab Beats Placebo for Reduction of Pruritus in Eczema
VAS score reduction greater at week 16 for addition of nemolizumab versus placebo to topical agents
Long-Acting Drug Targeting Capsid Protein Promising for HIV
Reduction of viral load seen nine days after dose; sustained plasma exposure seen for more than six months
February to March 2020 Saw Surge in Hydroxychloroquine Rx
Number of patients receiving hydroxychloroquine, chloroquine prescriptions climbed across the U.S.
